DEVICES FOR STROKE PREVENTION IN ATRIAL FIBRILLATION
Details
Unique design and advanced tips to optimize closure results:
Amulet >> David Hildick-Smith
Watchman >> Matthew Price
LAmbre >> Simon Lam
Omega >> Ignacio Cruz Gonzalez
SeaLA >> Horst Sievert
Epicardial LAA closure techniques >> Randall Lee
Vine filter and Capture II study >> Horst Sievert
Organised by
David Hildick-Smith
David Hildick-Smith is an interventional Cardiologist of national and international renown. He...
Read MoreDavid Hildick-Smith is an interventional Cardiologist of national and international renown. He undertakes procedures such as angioplasty, patent foramen ovale closure, atrial septal defect closure, left atrial appendage occlusion, transcatheter valve implantation and transcatheter mitral valve interventions. He does echocardiography onsite for relevant patients. He undertakes over 300 interventions per year at the Sussex Cardiac Centre and is Structural Heart lead for the British Cardiovascular Interventions Society.
Show LessHorst Sievert
A consultant cardiologist at CardioVascular Center, Frankfurt, Germany. Features in 63 videos on...
Read MoreA consultant cardiologist at CardioVascular Center, Frankfurt, Germany. Features in 63 videos on Wondr Medical. Horst Sievert generally speaks on Atrial Fibrillation, Left Atrial Appendage (Closure), Live Cases, Transcatheter Aortic Valve Implantation (TAVR / TAVI), and Left Main Stem (LMS).
Show LessLars Sondergaard
Professor Lars Søndergaard is a consultant cardiologist at Rigshospitalet – Copenhagen, Denmark....
Read MoreProfessor Lars Søndergaard is a consultant cardiologist at Rigshospitalet – Copenhagen, Denmark. Professor of Cardiology at University of Copenhagen, he published over 300 peer reviewed articles, and more than 15 textbook chapters. His research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions, as well as congenital and structural heart diseases. He led the first-in-human transcatheter mitral valve implantation (CardiAQ) in 2012 and he actively participated to several trials, including NOTION (transcatheter vs. surgical aortic valve replacement in patients with aortic stenosis and low surgical risk), and the REDUCE randomised trial (PFO vs anti-platelet therapy after cryptogenic stroke).
Show LessMatthew Price
Matthew Price, MD, is Director of the Cardiac Catheterization Laboratory and a member of the...
Read MoreMatthew Price, MD, is Director of the Cardiac Catheterization Laboratory and a member of the Division of Cardiovascular Diseases at Scripps Clinic, in La Jolla, California. Dr Price earned his medical degree from the University of California, Los Angeles (UCLA) School of Medicine and completed his internship and residency in internal medicine at the UCLA Center for Health Sciences. He subsequently completed a fellowship in Cardiovascular Diseases at Cedars-Sinai Medical Center in Los Angeles, where he held the position of Chief Fellow. Dr Price completed his training in interventional cardiology at Scripps Clinic, in La Jolla, California. Dr Price’s clinical and research focus includes interventional approaches to structural heart and coronary disease. He has led several clinical trials in PCI, and currently serves on the Steering and/or Executive committee of clinical trials evaluating antiplatelet therapy, novel drug-eluting stents, intravascular imaging, and left atrial appendage closure. He is a member of the Steering Committee of the ACC NCDR Left Atrial Appendage Occlusion (LAAO) registry. He has been twice awarded the Scripps Clinic Chairman’s Award for Research in Medicine. Dr Price serves as Editor-in-Chief of Interventional Cardiology Clinics and is a Section Editor for the Journal of the American College of Cardiology, He has authored or co-authored more than 140 peer-reviewed manuscripts, including publications in the New England Journal of Medicine, JAMA, the European Heart Journal, Circulation, and the Journal of the American College of Cardiology. He is also Editor of the seminal text-book, “Coronary Stenting”.
Show LessOle De Backer
Prof. Dr. Ole De Backer is an internationally renowned interventional cardiologist working at...
Read MoreProf. Dr. Ole De Backer is an internationally renowned interventional cardiologist working at Rigshospitalet, Copenhagen University Hospital, Denmark and is an expert in structural heart interventions (among others transcatheter heart interventions, percutaneous left atrial appendage closure and thoracic endovascular aortic repair). He is actively involved and leading several research projects in the field of transcatheter heart valves and percutaneous left atrial appendage closure.
Show LessRandall Lee
A cardiologist at UCSF School of Medicine, San Francisco, CA, USA. Features in 2 videos on Wondr...
Read MoreA cardiologist at UCSF School of Medicine, San Francisco, CA, USA. Features in 2 videos on Wondr Medical. Randall Lee generally speaks on Stroke: LAA and LAA closure, Closure, and Left Atrial Appendage (Closure).
Show LessShakeel Qureshi
A consultant pediatric cardiologist at Guys and St Thomas's NHS Trust, London, UK. Features in 46...
Read MoreA consultant pediatric cardiologist at Guys and St Thomas's NHS Trust, London, UK. Features in 46 videos on Wondr Medical. Shakeel Qureshi generally speaks on Covid-19, Covid19 Physician Insights, Transcatheter Aortic Valve Implantation (TAVR / TAVI), Stroke: LAA and LAA closure, and PFO/ASD (Closure).
Show LessSimon Lam
A consultant cardiologist at CardioVascular Center, Frankfurt, Germany. Features in 2 videos on...
Read MoreA consultant cardiologist at CardioVascular Center, Frankfurt, Germany. Features in 2 videos on Wondr Medical. Simon Lam generally speaks on ECHO Cardiography, 3d Transoesphageal Echo, and Congenital Heart Disease (CHD).
Show Less